Polymorphism in apoprotein-CIII gene and coronary heart disease

Annals of Saudi Medicine

Volumn 19, Issue 3, 1999, Pages 201-205

  Hussain, Syed S ^a   Buraiki, Jehad ^a   Dzimiri, Nduna ^a   Butt, Abdul Islam ^a   Vencer, Leticia ^a   Basco, Maria C ^a   Khan, Bashir ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Apoprotein CIII; Coronary heart disease; Polymorphism.

Indexed keywords

APOLIPOPROTEIN C3;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SMOKING;

EID: 0033400938     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.1999.201     Document Type: Article

References (25)

1. Rees A, Stocks J, Sharpe CR, Vella MA, Shoulders CC, Katz J, et al. Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster: association with hypertriglyceridemia. J Clin Invest 1985; 76:1090-5.
2. Tas S. Strong association of a single nucleotide substitution in the 3′-untranslated region of the apoliprotein-CIII gene with common hypertriglyceridemia in Arabs. Clin Chem 1989;35:256-9.
3. Henderson HE, London SV, Michie J, Berger GMB, Association of a DNA polymorphism in the apolipoprotein C-III gene with diverse hyperlipidemic phenotypes. Hum Genet 1987;75:62-5.
4. Ferns GA, Ritchie C, Stocks J, Galton DJ. Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction. Lancet 1985;II:300-3.
5. Ferns GA, Stocks J, Galton DJ. C-III DNA restriction fragment length polymorphism and myocardial infarction. Lancet 1986;I:94.
6. Trembath RC, Thomas DJB, Hendra TJ, Yudkin JS, Galton DJ. Deoxyribunucleic acid polymorphism of the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease in non-insulin-dependent diabetes. Br Med J 1987;296:1577-8.
7. Tas S. Genetic predisposition to coronary heart disease and gene for apolipoprotein-CIII. Lancet 1991;337:113-4.
8. Lopez-Miranda J, Ordovas JM, Espino A, Marin C, Salas J, Lopez-Segura F, et al. Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat. Lancet 1994;343:1246-9.
9. Morris SW, Price WH. DNA sequence polymorphisms in the apolipoprotein A-1/C-III gene cluster. Lancet 1985;II:1127-8.
10. Aalto-Setala K, Kontula K, Sane T, Nieminen M, Nikkila E. DNA polymorphisms of apolipoprotein A-1/CIII and insulin genes in familial hypertriglyceridemia and coronary heart diseases. Atherosclerosis 1987;66:145-52.
11. Rees A, Stocks J, Paul H, Ohuchi Y, Galton D. Haplotypes identified by DNA polymorphisms ai the apolipoprotein A-1 and C-III loci and hypertriglyceridemia: a study in a Japanese population. Hum Genet 1986;72:168-71.
12. Zeng Q, Dammerman M, Takada Y, Matsunaga A, Breslow JL, Sasaki J. An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population. Hum Genet 1995;95:371-5.
13. Wick U, Witt E, Engel W. Restriction fragment length polymorphisms at the apoprotein genes AI, CIII and B-100 and in the 5′ flanking region of the insulin gene as possible markers of coronary heart disease. Clin Genet 1995;47:184-90.
14. Dan Q, Huang Y, Peng Z. DNA polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster in coronary artery disease. Chung Hua I Hsueh Tra, Chih 1995;75:584-7.
15. Brown WV, Baginsky MI. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem Biophys Acta 1972;46:375-82.
16. Shelburne F, Hanks J, Meyers W, Quarfordt S. Effect of apolipoproteins on hepatic uptake of triglyceride emulsions in the rat. J Clin Invest 1980;65:652-8.
17. Windier E, Havel RJ. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by perfused rat liver. J Lipid Res 1985;26:556-65.
18. Aalto-Setala K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, et al. Mechanism of hypertriglyceridemia in human apolipoprotein (Apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Invest 1992;90: 1889-900.
19. Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL, Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 1990;249:790-3.
20. Miller SA, Dykes DD, Polesby HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988;16: 1215.
21. Price WH, Morris SW, Burgon R, Donald PM, Kitchin AH. Apolipoprotein CIII polymorphism and coronary heart disease. Lancet 1986;I:1041.
22. Kamel BS, Martinez OB. Food habits and nutrient intake of Kuwaiti males and females. Ecol Food Nutr 1985;15:261-72.
23. Slyper AH. Low-density lipoprotein density and atherosclerosis: unraveling the connection. JAMA Mid East 1994;IV:59-62.
24. Nikkila EA, Huttunen JK, Enhohn C. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus: relationship to plasma triglyceride metabolism. Diabetes 1977;26:11-21.
25. Steiner G, Lewis GF. Triglyceride-rich lipoprotein metabolism and diabetes. In: Gallo LL, editor. Cardiovascular disease. Vol. 2. Cellular and molecular mechanisms, prevention and treatment. New York: Plenum Press, 1995:49-55.